A Case of Low-Grade Fibromyxoid Sarcoma: A Rare Soft Tissue Sarcoma
DOI:
https://doi.org/10.37591/rrjos.v7i1.252Abstract
Sarcomas are heterogeneous group of tumours that can occur throughout the body. Approximately two third of soft tissue sarcomas (STS) arises in the extremities. These rare tumours accounts for less than 1% cancers in adults. Treatment algorithm for STS depends on tumour stage, site and histology. A 28-year-male patient presented with complaint of swelling over the right anterior aspect of leg since past six months. He had a history of injury over the same area 10 years back and was healed with scar. History of excision was three times within past six months. On examination, 6´7 cm swelling was present in right leg protruding, bleeds on touch, tender and local lymphadenopathy. Edge biopsy was done which showed haematoma. Magnetic resonance imaging (MRI) showed features suggestive of osteosarcoma after which excision biopsy was done and histopathologically, it was reported as low-grade fibromyxoid sarcoma-stage PT2bNxMx. After which wide local excision was done and patient was followed up. Multimodality treatment, including surgical resection, radiation therapy and in selected cases chemotherapy has been applied to patients with locally advanced, high-grade sarcomas. Overall 5 year survival rate for patients with all stages of STS is 50–60%. The most common site of metastases is in the lung and occurs within three years. Doxorubicin-based regimen has been the mainstay of treatment for past two decades; however, it is clear now that the specific histological subtypes have increased sensitivity to specific drugs.
Keywords: Sarcoma, fibromyxoid, fibromyxoid sarcoma
Cite this Article
Singhal N, Joshi CJ, Hanumanthappa MS. A Case of Low-Grade Fibromyxoid Sarcoma: A Rare Soft Tissue Sarcoma. Research & Reviews: Journal of Surgery. 2018; 7(1): 1–4p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have neither given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |